fda compounding glp-1 enforcement news US clarifies policies on of medicines FDA Intensifies Crackdown on GLP-1

The NTU teams findings suggest that GLP-1 receptor agonists could be a particularly effective option for diabetic patients at high risk for kidney complications

(Estudio que demostr el efecto pro-reparador de BPC-157 en lesiones de tendn de Aquiles en ratas

Further research remains warranted to address unanswered questions, such as whether DN results from global metabolic reprogramming of the PNS and how energy transfer or toxic byproducts between nerve cells contribute to the disease

doi:10.1111/joor.12801

Role of Amino Acids in the Body Proteins made from amino acids are essential for many biological processes

Most peptides do not have long term human safety data